UPDATE 2-Celgene raises 2017 revenue, profit forecast; maintains 2020 view
January 09, 2017 at 13:28 PM EST
Jan 9 (Reuters) - Celgene Corp on Monday raised its 2017 revenue and profit forecasts on the strength of its flagship Revlimid multiple myeloma drug and increased expectations for other treatments for cancer and psoriasis.
